Shandong, China, May 7, 2025 — Wixbio today announced the successful shipment of its customized Duck Adenovirus Inactivated Vaccine from its manufacturing site for customers in Vietnam. The shipment includes 500 vaccine vials designed to help Vietnamese farmers effectively prevent and control duck adenovirus infections and protect poultry health.
Duck adenovirus is a highly infectious and pathogenic pathogen for duck flocks. It can cause a wide range of serious diseases, including pericardial effusion and hepatitis, resulting in significant economic losses for the duck industry. In response to this threat, Wixbio has developed and produced a high-quality inactivated adenovirus vaccine to meet the needs of the Vietnamese market.
To ensure the activity and potency of the vaccines during transportation, all products are packed and shipped according to strict cold chain management standards. This not only ensures the vaccines’ safety but also reflects Wixbio’s strict requirements on product quality control.
The shipment of Duck Adenovirus Inactivated Vaccine to Vietnam marks Wixbio’s further expansion of its international presence and strengthens its relationship with its Southeast Asian partners. By providing efficient and safe animal healthcare solutions, Wixbio is committed to helping farmers worldwide cope with various disease challenges and promote the healthy development of the livestock industry.
